test

James B. Tananbaum

@Foresite Capital Management Iv, Llc

Latest period2024 - Q3ReportedManaged Assets$153.009MTotal holdings5
Assets growth rate2.8%Assets growth rate (2-Q avg)-10.99%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Foresite Capital Management Iv, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 5 positions.

Assets under management

The assets under management (AUM) of Foresite Capital Management Iv, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 153.009M in assets, with a quarterly growth rate of 2.8% and a 2-quarter average growth rate of -10.99%. The portfolio is managed by James B. Tananbaum, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PHVSPharvaris N.v.
Recent Activity
Increased 2.43%
53.24%
$81.449M
4.398M shares@ $18.52 avg price
KURAKura Oncology, Inc.
Recent Activity
23.63%
$36.148M
1.85M shares@ $19.54 avg price
SNDXSyndax Pharmaceuticals, Inc.
Recent Activity
11.01%
$16.844M
875,000 shares@ $19.25 avg price
LYELLyell Immunopharma, Inc.
Recent Activity
7.51%
$11.489M
8.325M shares@ $1.38 avg price
RLAYRelay Therapeutics Inc.
Recent Activity
New Position
4.63%
$7.08M
1M shares@ $7.08 avg price